Literature DB >> 10936786

Intra-tumoral cytolytic cells: pattern of distribution in B-cell non Hodgkin s lymphoma.

S Perambakam1, K Naresh, A Nerurkar, J Nadkarni.   

Abstract

Non-Hodgkin s lymphomas (NHLs) constitute a heterogeneous group of lymphoid neoplasms and a majority of them in India are of B-cell phenotype. Varying numbers of T lymphocytes and natural killer (NK) cells are consistently present within the lymph nodes (LNs). The role of these reactive cells is becoming understood. TIA-1 is a cytotoxic granule associated RNA binding protein, the expression of which is restricted to cytotoxic T lymphocytes (CTLs) and NK cells. Snap frozen lymph node biopsies obtained from 41 B-cell NHLs were localized for intra-tumoral TIA-1 + cytolytic cells by immunohistochemistry. Distribution of T cell subsets and NK cells were also quantified. Cells expressing TIA-1 antigen was observed in all the cases, seen as a strong granular cytoplasmic signal. Results indicate significantly higher number of TIA-1 cytolytic cells outside (periphery of the follicle and interfollicular areas) than within the neoplastic follicle in follicular lymphomas (p<0.001). In small lymphocytic lymphomas, cytolytic cells were mainly seen as uniformly scattered single cells, distributed throughout the tumor environment. In mantle cell and diffuse large B-cell lymphomas these were most often seen as small clusters and less frequently as singly scattered cells. Higher numbers of CD4 + than the CD8 + T cells were observed in most cases. Contrary to the follicles in follicular hyperplasia, CD57 + NK cells were predominantly observed outside the neoplastic follicle in follicular lymphomas (FLs). These results outline specific interactions between the potential anti-tumoral cytolytic and the malignant cells of B-cell NHLs.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10936786     DOI: 10.1007/bf03032360

Source DB:  PubMed          Journal:  Pathol Oncol Res        ISSN: 1219-4956            Impact factor:   3.201


  14 in total

1.  A monoclonal antibody reactive with a 15-kDa cytoplasmic granule-associated protein defines a subpopulation of CD8+ T lymphocytes.

Authors:  P Anderson; C Nagler-Anderson; C O'Brien; H Levine; S Watkins; H S Slayter; M L Blue; S F Schlossman
Journal:  J Immunol       Date:  1990-01-15       Impact factor: 5.422

2.  A polyadenylate binding protein localized to the granules of cytolytic lymphocytes induces DNA fragmentation in target cells.

Authors:  Q Tian; M Streuli; H Saito; S F Schlossman; P Anderson
Journal:  Cell       Date:  1991-11-01       Impact factor: 41.582

3.  Non-Hodgkin's lymphoma: cytotoxic T lymphocyte mediated activity correlated with histopathological classification and staging.

Authors:  S Perambakam; K Naresh; C Soman; S Advani; J Nadkarni
Journal:  Cancer Biother Radiopharm       Date:  1997-02       Impact factor: 3.099

4.  Cytolytic (TIA-1+) tumor infiltrating lymphocytes in B cell non-Hodgkin's lymphomas. SWOG Central Repository Members.

Authors:  J Diaz; R Tubbs; M Stoler; T Grogan
Journal:  Leuk Lymphoma       Date:  1993-01

5.  T-lymphocyte subsets in follicular lymphomas compared with those in non-neoplastic lymph nodes and tonsils.

Authors:  P Dvoretsky; G S Wood; R Levy; R A Warnke
Journal:  Hum Pathol       Date:  1982-07       Impact factor: 3.466

6.  Activated T-cell subsets in benign lymphoid hyperplasias and B-cell non-Hodgkin's lymphomas.

Authors:  J I Diaz; M G Edinger; M H Stoler; R R Tubbs
Journal:  Am J Pathol       Date:  1991-09       Impact factor: 4.307

7.  Distribution of T-cell subsets in follicular and diffuse lymphomas of B-cell type.

Authors:  N L Harris; A K Bhan
Journal:  Am J Pathol       Date:  1983-11       Impact factor: 4.307

8.  Blood and lymph node T-lymphocyte subsets in non-Hodgkin lymphomas.

Authors:  C Lindemalm; H Mellstedt; P Biberfeld; M Björkholm; B Christensson; G Holm; B Johansson; R Sundblad
Journal:  Scand J Haematol       Date:  1983-01

Review 9.  A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group.

Authors:  N L Harris; E S Jaffe; H Stein; P M Banks; J K Chan; M L Cleary; G Delsol; C De Wolf-Peeters; B Falini; K C Gatter
Journal:  Blood       Date:  1994-09-01       Impact factor: 22.113

10.  Numbers of host "helper" T cells and proliferating cells predict survival in diffuse small-cell lymphomas.

Authors:  L J Medeiros; L J Picker; A B Gelb; J G Strickler; S W Brain; L M Weiss; S J Horning; R A Warnke
Journal:  J Clin Oncol       Date:  1989-08       Impact factor: 44.544

View more
  3 in total

1.  Expansion of CD4+ T cells with a cytotoxic phenotype in patients with B-chronic lymphocytic leukaemia (B-CLL).

Authors:  N Porakishvili; T Roschupkina; T Kalber; A P Jewell; K Patterson; K Yong; P M Lydyard
Journal:  Clin Exp Immunol       Date:  2001-10       Impact factor: 4.330

2.  A Tridimensional Model for NK Cell-Mediated ADCC of Follicular Lymphoma.

Authors:  Emilie Decaup; Cédric Rossi; Pauline Gravelle; Camille Laurent; Julie Bordenave; Marie Tosolini; Anne Tourette; Emeline Perrial; Charles Dumontet; Mary Poupot; Christian Klein; Ariel Savina; Jean-Jacques Fournié; Christine Bezombes
Journal:  Front Immunol       Date:  2019-08-14       Impact factor: 7.561

3.  Systemic and Intra-Nodal Activation of NK Cells After Rituximab Monotherapy for Follicular Lymphoma.

Authors:  Monika Enqvist; Benedikt Jacobs; Henna R Junlén; Marie Schaffer; Christopher M Melén; Danielle Friberg; Björn Engelbrekt Wahlin; Karl-Johan Malmberg
Journal:  Front Immunol       Date:  2019-09-12       Impact factor: 7.561

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.